Boothbay Fund Management, LLC Affimed N.V. Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.54 - $7.51 $58,934 - $79,891	-10,638 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.78 - $11.4 $82,763 - $121,273	10,638 New	10,638 $90,000
Q2 2019 Aug 14, 2019	SELL	$2.6 - $4.21 $395,200 - $639,920	-152,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.05 - $4.34 $463,600 - $659,680	152,000 New	152,000 $638,000

1.09M

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $600M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.